Advisors Management Group’s AbbVie ABBV Stock Holding History

Advisors Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$200K	Sell	798 -237	-23%	-$51K	0.03%	155
2026 Q1	$225K	Sell	1,035 -2	-0.2%	-$444	0.04%	149
2025 Q4	$237K	Sell	1,037 -9	-0.9%	-$2.05K	0.04%	147
2025 Q3	$242K	Buy	+1,046	New	+$213K	0.04%	143
2025 Q2	–	Sell	-1,059	Closed	-$222K	–	149
2025 Q1	$222K	Buy	+1,059	New	+$206K	0.05%	141
2024 Q4	–	Sell	-1,058	Closed	-$209K	–	151
2024 Q3	$209K	Buy	+1,058	New	+$197K	0.05%	145
2024 Q2	–	Sell	-1,242	Closed	-$226K	–	155
2024 Q1	$226K	Buy	+1,242	New	+$214K	0.06%	145
2023 Q1	–	Sell	-1,843	Closed	-$298K	–	142
2022 Q4	$298K	Buy	1,843 +12	+0.7%	+$1.84K	0.11%	101
2022 Q3	$246K	Buy	1,831 +188	+11%	+$27K	0.1%	109
2022 Q2	$252K	Buy	1,643 +49	+3%	+$7.49K	0.09%	111
2022 Q1	$258K	Buy	1,594 +3	+0.2%	+$436	0.09%	109
2021 Q4	$215K	Buy	+1,591	New	+$188K	0.06%	123

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Advisors Management Group's ABBV Position: Q2 2026 in Review

Advisors Management Group reduced its AbbVie (ABBV) stake by 23% in Q2 2026, selling an estimated $51K and leaving 798 shares worth $200K. The position accounts for 0.03% of the portfolio, ranked #155.

Advisors Management Group first reported a position in ABBV in Q4 2021 and has held it in 12 quarters since. The position peaked at $298K in Q4 2022. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Advisors Management Group held 798 shares of AbbVie worth $200K as of Q2 2026.
Advisors Management Group sold 237 AbbVie shares in Q2 2026, an estimated $51K.
AbbVie made up 0.03% of Advisors Management Group's portfolio in Q2 2026, its #155 holding.
Advisors Management Group first reported a position in AbbVie in Q4 2021 and has held it in 12 quarters since.
Advisors Management Group's AbbVie position peaked at $298K in Q4 2022.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Advisors Management Group's 13F filing for Q2 2026, filed 4 Aug 2026.